A-shares closed · 港股休市 Quotes 行情 · 28 Sep 12:51 CST
28 Sep 2026 · 12:51 CST Terminal Access 终端入口 →
688046.SH上海证券交易所 · 科创板 STAR

Gempharmatech 药康生物

Healthcare Services 医疗服务
¥35.26−¥0.66 · −1.84%Delayed 行情延迟 · 28 Sep 2026 · 12:05 CST · CNY
Open 开盘
¥35.99
High 最高
¥36.40
Low 最低
¥35.18
Prev Close 昨收
¥35.92
Volume 成交量
493.1万股
Turnover 成交额
¥1.76亿
Mkt Cap 总市值
¥145亿
P/E 市盈率
79.2×
Recent Activity 近期动态All Filings 全部公告 →

6 significant filings since 31 May 2026: 2 on change of interest, 2 on equity incentive and 1 on earnings pre-announcement, and 1 other kind. The latest, on 3 Sep 2026: 简式权益变动报告书. On 22 Jul 2026 the company said it expects net profit for the period ending 30 Jun 2026 to rise by 46.67% to 60.78% from the same period a year earlier.
自 31 May 2026 起有 6 份重大公告:change of interest 2 份、equity incentive 2 份、earnings pre-announcement 1 份,另有 1 类。最新一份(3 Sep 2026):简式权益变动报告书。22 Jul 2026 公司预告截至 30 Jun 2026 的净利润较上年同期上升 46.67% 至 60.78%。

Price History 价格走势

22 trading days 个交易日 · High 最高 ¥38.61 · Low 最低 ¥29.79
30.0032.0034.0036.0038.00
Volume 成交量
1,452.7万
26 Aug02 Sep09 Sep17 Sep24 Sep

Against Its Own History 与自身历史比较

79.2×
Median 中值 51.1× · Range 区间 26.2× to 68.4× · 17 periods 期
6.38×
Median 中值 3.36× · Range 区间 1.98× to 6.36× · 17 periods 期

Period by Period 逐期

Period 报告期Close at Period End 期末收盘TTM EPS 滚动每股收益 BPS 每股净资产
30 Jun 2026 中报¥24.20¥0.4553.8×¥5.534.38×
31 Mar 2026 一季报¥14.48¥0.4036.2×¥5.562.61×
31 Dec 2025 年报¥15.36¥0.3543.9×¥5.432.83×
30 Sep 2025 三季报¥18.06¥0.3060.2×¥5.373.36×
30 Jun 2025 中报¥15.04¥0.2560.2×¥5.292.84×
31 Mar 2025 一季报¥13.80¥0.2751.1×¥5.272.62×
31 Dec 2024 年报¥12.85¥0.2747.6×¥5.212.47×
30 Sep 2024 三季报¥14.79¥0.3443.5×¥5.182.86×
30 Jun 2024 中报¥10.22¥0.3926.2×¥5.151.98×
31 Mar 2024 一季报¥12.86¥0.3833.8×¥5.202.47×
31 Dec 2023 年报¥20.15¥0.3951.7×¥5.183.89×
30 Sep 2023 三季报¥17.20¥0.3845.3×¥5.083.39×
30 Jun 2023 中报¥19.39¥0.3949.7×¥4.983.89×
31 Mar 2023 一季报¥24.40¥0.4258.1×¥4.904.98×
31 Dec 2022 年报¥24.05¥0.4257.3×¥4.824.99×
30 Sep 2022 三季报¥30.10¥0.4468.4×¥4.736.36×
30 Jun 2022 中报¥29.30¥0.4466.6×¥4.626.34×

Consensus Forward EPS 机构预测每股收益

Fiscal Year 年度EPS Median 中值Range 区间Brokers 机构数Forward P/E 预测市盈率
2026¥0.57¥0.57 to ¥0.57161.9×
2027¥0.77¥0.77 to ¥0.77145.8×
2028¥0.92¥0.92 to ¥0.92138.3×
Not Computed 未计算
  • Dividend Yield 股息率
  • Free Cash Flow 自由现金流
  • EV/EBITDA